U.S., July 17 -- ClinicalTrials.gov registry received information related to the study (NCT07707778) titled 'Tirzepatide's Effects on Epigenetic Aging and Metabolic Restoration in Virally Suppressed People With HIV' on July 01.
Brief Summary: This study is a pilot, open-lable, two-arm study. The investigators will enroll virally suppressed people living with HIV and obesity to evaluate the effect of tirzepatide on epigenetic aging, assessed by DNA methylation-based clocks using peripheral blood. In parallel, imaging studies will be performed to assess changes in body composition and intrahepatic fat content.
Study Start Date: June 25
Study Type: INTERVENTIONAL
Condition:
Human Immunodeficiency Virus (HIV)
Metabolic Dysfunction Associat...